Non-prescription drug products are classified as over-the-counter (OTC) drug products. OCT products are drugs that are effective and safe for use by the public without treatment from health professionals. The Food and Drug Administration’s (FDA) review of OCT drugs is handled by the Center for Drug Evaluation and Research’s (CDER) Office of Nonprescription Drugs.1

There are more than 300,000 marketed OTC drugs that the FDA reviews for active ingredients; however, the labeling is reviewed for each one of the 80 therapeutic classes of drugs such as antacids. For each drug class, an OTC monograph is developed and published, as a guideline covering the accepted dosage, formulations, ingredients, and labels. After the monograph is implemented, manufacturers can make and market OTC products without FDA pre-approval.

New OTC products which conform to the OTC monograph classes are marketable without FDA review. If a product does not conform with the monographs, it should be reviewed following the New Drug Application process. A drug manufacturer can petition to change an implemented monograph to include modified labeling or additional ingredients.

Regulatory FDA guidance documents include the processes and evaluations for new OTC drug products. Additional information on regulatory laws policies and procedures for OTC products can be accessed on the Federal Register and within the Code of Federal Regulations. If your company needs assistance with New Drug Applications, OTC drug products monograph petitions, or navigating through the FDA guidance documents, EMMA International is here to help. Contact us by phone at 248-987-4497 or by email at info@emmainternational.com.

_____________________

[1] FDA (March 2020) Drug Applications for Over-the-Counter Drugs. Retrieved on April 18, 2022, from https://www.fda.gov/drugs/types-applications/drug-applications-over-counter-otc-drugs

Sarah Koehler

Sarah Koehler

Sarah is a Quality Engineer at EMMA International. She has experience in quality assurance, change management, laboratory controls, and process/equipment validation within the pharmaceutical and medical device industry. Sarah has earned a Bachelor of Science in Chemical Engineering from Western Michigan University.

More Resources

Process Validation

Process Validation

All right, you have just gotten all of your paperwork together, submitted the right forms to the right people, set up your factory, hired and trained your staff; now it’s time to make the medical devices. The regulatory nonsense is over and done, right?
The Role of Management in Product Quality

The Role of Management in Product Quality

Depending on the factory, some production employees may find it surprising that management has an important role to play in a quality system.  21 CFR 820.20 mandates that “Management with executive responsibility shall establish objectives for, and commitment to, quality”.[1]  The Federal Government expects that management takes an active interest in improving the output of their company, at least in the case of medical device manufacturers.
Corrective and Preventive Action

Corrective and Preventive Action

In addition to helping manufacturers make better products, corrective and preventive actions are important because the process is legally required by the FDA when making medical devices for the US market.

Ready to learn more about working with us?

Pin It on Pinterest

Share This